Novartis India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

672.25

-17.10 (-2.48%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

672.25

-17.10 (-2.48%)
15:57 Oct 25

Quality

79/100
High Financial Strength

Valuation

43/100
Mid Valuation

Technical

36/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	381.35	399.87	378.74	335.07	345.1
Operating Expenses +	354.56	372.76	313.66	269.81	272.19
Raw Material	135.88	187.26	199.34	189.98	197.38
Increase Decrease in Cost	10.74	-9.13	2.35	9.86	8.07
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	108.51	101.89	35.64	22.96	22.15
Miscellaneous Expenses	371.19	467.26	475.01	426.97	44.59
Operating Profit	26.79	27.11	65.08	65.26	72.91
Other Income	33.09	33.19	58.11	61.68	53.11
Depreciation	12.16	9.65	6.06	2.61	1.53
Interest	7.68	4.83	1.75	1.49	0.61
Profit before tax and exceptio..	40.04	45.82	115.38	122.84	123.88
Exceptional Items	0	-49.64	0	0	0
PBT	40.04	-3.82	115.38	122.84	123.88
Provision for Taxation	19.14	-0.1	12.02	37.65	36.48
Net Profit	20.9	-3.72	103.36	85.19	87.4
NET Profit after MI	0	0	0	0	0
EPS	8.46	-1.51	41.86	34.5	58.01
Operating Profit Margin (%)	7.03	6.78	17.18	19.48	21.13
Net Profit Margin (%)	5.48	-0.93	27.29	25.42	25.33

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	70.70	70.70	70.70	70.70	70.70
FII	0.20	0.20	0.20	0.20	0.30
MF	0.00	0.00	0.00	0.00	0.00
Public	28.60	28.60	28.60	28.60	28.50
Others	0.00	0.00	0.00	0.00	0.00
Others	0.50	0.50	0.50	0.50	0.50